Texas

FDA Commissioner Scott Gottlieb said the agency has changed its approach to the opioid crisis and will take a more aggressive approach on regulatory actions.

During his two years in office, former Texas Secretary of State Rolando Pablos flexed the muscles of his office to make recruiting biotech and pharma companies a priority.

If you’re in the pharma or biotech industry and are looking for work, multiple companies have announced expansions of their employee pool over the past few days. BioSpace rounds up a few of the announcements.

Following international concern and outrage over a gene editing treatment of human embryos in China, the World Health Organization is taking action.

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

Lawmakers continue to hear concerns over drug prices, as well as proposals to fix the issue.

First reported by the San Antonio Business Journal, the company will cut about 265 employees, 200 from its Alamo City site and the rest from its Charlotte facility. The cuts are part of a restructuring and will be handled over time, rather than all in one fell swoop of pink slips.

Alexander (Sasha) Opotowsky, associate professor at Harvard Medical School and a cardiologist at Boston Children’s Hospital and Brigham and Women’s Hospital took time out to speak with BioSpace about advances in heart health, congenital heart disease (CHD), biopharma, and the Adult Congenital Heart Association (ACHA).

In this week’s edition of Movers and Shakers, biopharma companies tap executives to serve in various leadership roles.

Despite a decline over the past year of class-action lawsuits, life science companies remain a popular target for securities fraud litigation.